Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
47,814,937
-
Share change
-
+588,581
-
Total reported value
-
$684,558,740
-
Put/Call ratio
-
100%
-
Price per share
-
$14.42
-
Number of holders
-
150
-
Value change
-
-$26,663,745
-
Number of buys
-
81
-
Number of sells
-
84
Institutional Holders of AIMMUNE THERAPEUTICS INC - COM (AIMT) as of Q1 2020
As of 31 Mar 2020,
AIMMUNE THERAPEUTICS INC - COM (AIMT) was held by
150 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,814,937 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock Inc., Palo Alto Investors LP, FMR LLC, STATE STREET CORP, VICTORY CAPITAL MANAGEMENT INC, FIERA CAPITAL CORP, and Point72 Asset Management, L.P..
This page lists
150
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.